List of Tables

Table 1 List of abbreviation
Table 2 North America oncology companion diagnostic market, by region, 2025 - 2033 (USD Million)
Table 3 North America oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 4 North America oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 5 North America oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 6 North America oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 7 U.S. oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 8 U.S. oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 9 U.S. oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 10 U.S. oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 11 Canada oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 12 Canada oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 13 Canada oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 14 Canada oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 15 Mexico oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 16 Mexico oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 17 Mexico oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 18 Mexico oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 19 Europe oncology companion diagnostic market, by region, 2025 - 2033 (USD Million)
Table 20 Europe oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 21 Europe oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 22 Europe oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 23 Europe oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 24 Germany oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 25 Germany oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 26 Germany oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 27 Germany oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 28 UK oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 29 UK oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 30 UK oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 31 UK oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 32 France oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 33 France oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 34 France oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 35 France oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 36 Italy oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 37 Italy oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 38 Italy oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 39 Italy oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 40 Spain oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 41 Spain oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 42 Spain oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 43 Spain oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 44 Denmark oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 45 Denmark oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 46 Denmark oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 47 Denmark oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 48 Sweden oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 49 Sweden oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 50 Sweden oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 51 Sweden oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 52 Norway oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 53 Norway oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 54 Norway oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 55 Norway oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 56 Asia Pacific oncology companion diagnostic market, by region, 2025 - 2033 (USD Million)
Table 57 Asia Pacific oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 58 Asia Pacific oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 59 Asia Pacific oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 60 Asia Pacific oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 61 China oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 62 China oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 63 China oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 64 China oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 65 Japan oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 66 Japan oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 67 Japan oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 68 Japan oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 69 India oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 70 India oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 71 India oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 72 India oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 73 South Korea oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 74 South Korea oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 75 South Korea oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 76 South Korea oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 77 Australia oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 78 Australia oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 79 Australia oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 80 Australia oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 81 Thailand oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 82 Thailand oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 83 Thailand oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 84 Thailand oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 85 Latin America oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 86 Latin America oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 87 Latin America oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 88 Latin America oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 89 Brazil oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 90 Brazil oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 91 Brazil oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 92 Brazil oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 93 Argentina oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 94 Argentina oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 95 Argentina oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 96 Argentina oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 97 MEA oncology companion diagnostic market, by region, 2025 - 2033 (USD Million)
Table 98 MEA oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 99 MEA oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 100 MEA oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 101 MEA oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 102 South Africa oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 103 South Africa oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 104 South Africa oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 105 South Africa oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 106 Saudi Arabia oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 107 Saudi Arabia oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 108 Saudi Arabia oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 109 Saudi Arabia oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 110 UAE oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 111 UAE oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 112 UAE oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 113 UAE oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)
Table 114 Kuwait oncology companion diagnostic market, By Offering , 2025 - 2033 (USD Million)
Table 115 Kuwait oncology companion diagnostic market, by technology, 2025 - 2033 (USD Million)
Table 116 Kuwait oncology companion diagnostic market, by disease, 2025 - 2033 (USD Million)
Table 117 Kuwait oncology companion diagnostic market, by end use, 2025 - 2033 (USD Million)

List of Figures

Fig. 1 Oncology companion diagnostic market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Segment snapshot-2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter’s five force analysis
Fig. 18 PESTEL analysis
Fig. 19 Oncology companion diagnostic market: Product & Services outlook key takeaways
Fig. 20 Oncology companion diagnostic market: Product & Services movement analysis
Fig. 21 Passive immunization market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 22 Preventive vaccines market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 23 Oncology companion diagnostic market: Technology outlook key takeaways
Fig. 24 Oncology companion diagnostic market: Technology movement analysis
Fig. 25 Monoclonal antibodies market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 26 Next-generation Sequencing (NGS) market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 27 mRNA-based vaccine market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 28 Other Technologies market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 29 Oncology companion diagnostic market: Disease Type outlook key takeaways
Fig. 30 Oncology companion diagnostic market: Disease Type movement analysis
Fig. 31 Breast Cancer market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 32 Non-small Cell Lung Cancer market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 33 Colorectal Cancer market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 34 Leukemia market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 35 Melanoma market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 36 Prostate Cancer market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 37 Others estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 38 Oncology companion diagnostic market: End Use outlook key takeaways
Fig. 39 Oncology companion diagnostic market: End Use movement analysis
Fig. 40 Hospital & retail pharmacies market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 41 Government suppliers market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 42 Academic Medical Center market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 43 Regional marketplace outlook, 2024 & 2030 (USD million)
Fig. 44 Regional marketplace: Key takeaways
Fig. 45 North America Oncology companion diagnostic market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 46 Key country dynamics
Fig. 47 U.S. Oncology companion diagnostic market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 48 Key country dynamics
Fig. 49 Canada Oncology companion diagnostic market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 Mexico Oncology companion diagnostic market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 52 Europe Oncology companion diagnostic market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 UK Oncology companion diagnostic market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 Germany Oncology companion diagnostic market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 France Oncology companion diagnostic market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Spain Oncology companion diagnostic market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Italy Oncology companion diagnostic market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Denmark Oncology companion diagnostic market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Sweden Oncology companion diagnostic market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Norway Oncology companion diagnostic market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 69 Asia Pacific Oncology companion diagnostic market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Japan Oncology companion diagnostic market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 China Oncology companion diagnostic market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 India Oncology companion diagnostic market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 Australia Oncology companion diagnostic market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 South Korea Oncology companion diagnostic market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 Thailand Oncology companion diagnostic market estimates and forecasts, 2025 - 2033 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 Market participant categorization
Fig. 84 Oncology companion diagnostic market position analysis, 2024
Fig. 85 Strategic framework